
Sequential Treatment of Extra-Corporeal Shock Wave Combined With aUtologous Bone marRow Mesenchymal...
Ischemic Heart DiseaseThis study is designed to evaluate the efficacy, safety and tolerability of autologous bone marrow derived mesenchymal stem cells compared to placebo (sham operation) when administered via percutaneous coronary infusion to patients with ischemic heart disease, who are screened by D-SPECT and have pretreated with 3-month cardiac shock wave therapy.

Cardiac Metabolic Modulator Treatment for Improvement of Diastolic Function in Patients With Coronary...
Coronary Heart DiseaseDiastolic DysfunctionBased on accumulating evidence showing that impaired cardiac energetic metabolism plays important role in the mechanism of cardiac diastolic dysfunction,the study is designed to evaluate whether metabolic modulator treatment with trimetazidine could have beneficial effects on patients with coronary heart disease(CHD) and ventricular diastolic dysfunction.This study is a prospective,randomised,open-label trial to assess the efficacy of trimetazidine treatment in improving diastolic function in CHD patients with diastolic dysfunction.

Dyspnea Assessment in Hemodialysis Patients
Dyspnea; UremicEnd Stage Renal Disease4 moreShortness of breath is very common among patients on dialysis for kidney failure; however, its causes are often not understood. This study will explore the lungs and the heart of these patients to determine the causes of shortness of breath. The amount of salt in the body tissues, which tends to accumulate in dialysis patients and can also cause shortness of breath, will also be measured. Machines that exploit magnetic resonance, ultrasound and x-rays to take images of the body interior will be employed; in addition, breathing tests, questionnaires and blood tests will also be used. 20 patients on dialysis will be recruited and have two visits: one at the beginning of the study and one year later to observe any changes in the lungs, heart and salt accumulation over time.

Comparison Between Propofol and Inhalational Anaesthetic Agents on Cardiovascular Outcomes Following...
Coronary Heart DiseaseCardiovascular DiseasesThe objective of this research proposal is to find out whether comparing the two different anaesthetic maintenance techniques (Propofol vs volatile anaesthetics) in adult patients undergoing heart surgery is practical for the anaesthetist treating the patients and whether it is feasible for the research team to recruit patients and follow them up after the operation.

The Wild Man Programme - a Nature-based Rehabilitation Enhancing Quality of Life for Men on Long-term...
StressAnxiety5 moreThe aim of the present study is to examine whether the nature based 'Wild man Programme' can help to increase quality of life among men on sick leave compared to treatment as usual. Additionally, the study examines which natural environments best work as supportive environments in the rehabilitation.

Effect of Trunk Stabilizing Exercises on Patients With Median Sternotomy After Heart Valve Surgery...
Valvular Heart DiseasePURPOSE: The aim of this study is to investigate the effect of trunk stabilizing exercises on sternal instability in patients with median sternotomy after heart valve surgery

High Dose Methylprednisolone Verses Low Dose in Correction of Congenital Acynotic Heart Disease...
AnesthesiaTo compare the effect of low dose methylprednisolone versus high dose on inflammatory mediators' level and cardioprotective effect after CPB in correction of congenital acyanotic heart disease.

The Effect of L-Citrulline Malate on Ankle Brachial Index Among Patients With Coronary Heart Disease...
Coronary Heart DiseaseIn this randomized clinical trial before and after study we will assess the effect of L-citrulline malate on brachial index in patients with coronary heart disease based on their smoking history. Twenty patients with coronary heart disease with no history of diabetes or other chronic diseases and with no history of myocardial infarction in the last 6 months will participate in our trial.A written well-versed permission was attained from all patients. We will measure the brachial index tow times once before giving L-Citrulline malate and the other time after 2 weeks giving it.Patients receiving L-Citrulline malate as a 1 gram dry powder agent twice a day, that should in use with 250 mg dilute water .The patients will followed after 2 weeks by measuring brachial index which is our primary outcome measurement in this trial.We assumed that the brachial index in both smoker and non-smoker group of patients with coronary heart disease would change to normal or close to normal after giving 1 gram L-citrulline malate twice a day for 2 weeks.

Optimal dRug Eluting steNts Implantation Guided By Intravascular Ultrasound and Optical coheRence...
Coronary Artery DiseaseCoronary Disease1 moreThe objective of this research is to assess the clinical results of implantation of different drug eluting stents under "aggressive" intravascular ultrasound (IVUS) guided all the way up to 24 months after operation and to establish the significance of the data of an optical coherent tomography (OCT) for the assessment of direct results of stenting and the degrees of endothelization of stent after 6 months. The following hypothesis formed the base for this study: IVUS guided intervention allows to improve the results and increase the safety of implantation drug eluting stents. Suboptimal results according to IVUS data can influence the follow up results of treatment. Suboptimal results according to OCT data, which are not revealed by IVUS, can influence the follow up results of treatment. The use of strategy of stenting with the achievement of optimal results under the intravascular methods of visualization allows to reduce the time of application of antiplatelet therapy. The modern limus-eluting stents do not differ in the follow up results in investigated criteria.

A Randomized Clinical Evaluation of the BioFreedom™ Stent
Stable AnginaIschemic Heart Disease Silent3 moreThe purpose of this study is to demonstrate that a BioFreedom™ Drug Coated Stent is non-inferior to a bare metal stent at one year as measured by the composite safety endpoint of cardiovascular death, myocardial infarction and definite/probable stent thrombosis, and that its efficacy is superior to a bare metal stent as measured by clinically driven TLR at one year.